CN Stock MarketDetailed Quotes
600572 Zhejiang Conba Pharmaceutical
- 4.81
- -0.13-2.63%
Market Closed Dec 13 15:00 CST
12.36BMarket Cap25.45P/E (TTM)
4.94High4.79Low511.35KlotVolume4.91Open4.94Pre Close247.88MTurnover2.00%Turnover Ratio20.91P/E (Static)2.57BShares5.5452wk High1.86P/B12.33BFloat Cap3.8752wk Low5.43Limit Up2.56BShs Float12.13Historical High4.45Limit Down3.04%Amplitude-0.82Historical Low0.20Dividend TTM4.85Avg Price346.51KlotAsk4.16%Div YieldTTM100Lot Size159.63KlotBid
Zhejiang Conba Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.23%4.91B | -8.40%3.45B | -14.38%1.82B | 12.20%6.73B | 15.51%5.18B | 22.19%3.76B | 25.27%2.13B | -8.64%6B | -8.68%4.49B | -1.24%3.08B |
| Operating revenue | -5.23%4.91B | -8.40%3.45B | -14.38%1.82B | 12.20%6.73B | 15.51%5.18B | 22.19%3.76B | 25.27%2.13B | -8.64%6B | -8.68%4.49B | -1.24%3.08B |
| Other operating revenue | ---- | 3.33%42.53M | ---- | 46.66%80.59M | ---- | 68.09%41.16M | ---- | 45.88%54.95M | ---- | 86.75%24.49M |
| Total operating cost | -1.27%4.43B | -4.56%3.05B | -10.73%1.58B | 13.49%5.99B | 15.64%4.49B | 20.60%3.2B | 23.04%1.76B | -9.79%5.28B | -10.29%3.88B | -3.07%2.65B |
| Operating cost | 12.74%2.27B | 10.49%1.56B | 6.98%784.25M | 14.46%2.8B | 17.11%2.02B | 18.69%1.41B | 17.35%733.11M | -4.15%2.44B | -4.57%1.72B | 11.34%1.19B |
| Operating tax surcharges | -2.16%60.15M | -11.09%40.02M | 5.18%24.52M | 14.05%84.98M | 12.30%61.47M | 23.39%45.01M | 9.91%23.31M | -5.44%74.51M | -6.39%54.74M | -4.92%36.48M |
| Operating expense | -18.80%1.51B | -21.83%1.09B | -28.43%590.73M | 10.91%2.29B | 16.03%1.86B | 25.67%1.4B | 32.80%825.37M | -14.94%2.06B | -15.58%1.6B | -13.62%1.11B |
| Administration expense | -0.74%393.61M | -6.74%247.35M | -8.84%125.49M | 4.98%545.78M | 7.46%396.57M | 16.92%265.24M | 16.39%137.65M | -3.87%519.89M | -3.66%369.05M | -1.60%226.86M |
| Financial expense | -54.58%-12.21M | -76.27%-14.86M | -717.42%-9M | -30.77%-18.67M | 3.53%-7.9M | -218.65%-8.43M | -52.02%1.46M | -124.34%-14.28M | -117.74%-8.19M | -108.15%-2.65M |
| -Interest expense (Financial expense) | -38.31%19.42M | -33.39%14.54M | -40.07%8.19M | -26.42%36.4M | -20.58%31.49M | -25.12%21.83M | -9.03%13.66M | -32.43%49.47M | -30.06%39.65M | -25.25%29.16M |
| -Interest Income (Financial expense) | 12.63%-32.26M | -3.85%-27.16M | -19.66%-15.94M | 4.60%-53.01M | 6.14%-36.92M | 4.14%-26.16M | -10.34%-13.33M | -258.41%-55.57M | -226.54%-39.34M | -242.09%-27.29M |
| Research and development | 26.71%208.22M | 43.36%133.5M | 35.68%59.38M | 52.31%298.09M | 14.77%164.33M | -1.69%93.12M | -3.92%43.76M | -3.35%195.72M | 3.43%143.19M | 13.22%94.72M |
| Credit Impairment Loss | 11.58%-6.16M | -36.86%-7.73M | -138.40%-6.4M | -352.58%-1.07M | -85.43%-6.97M | -60.36%-5.65M | 43.13%-2.68M | 99.36%-235.55K | 26.89%-3.76M | 42.50%-3.52M |
| Asset Impairment Loss | 68.82%-7.64M | 19.69%-12.29M | -291.97%-12.44M | 16.54%-57.65M | -41.29%-24.5M | -64.88%-15.31M | -1,116.13%-3.17M | 72.43%-69.07M | -391.00%-17.34M | -962.37%-9.28M |
| Adjustment items of total operating cost | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 58.78%172.6M | 1.00%90.94M | -55.78%21.4M | 140.44%47.78M | 160.40%108.7M | 221.03%90.04M | 159.63%48.39M | -106.49%-118.13M | 7.01%-179.97M | -781.26%-74.39M |
| Fair value change income | 128.62%23.67M | 93.92%-2.19M | 181.26%2.64M | 31.93%-134.92M | 65.82%-82.71M | 70.89%-36.09M | 96.78%-3.25M | 68.91%-198.2M | 15.45%-241.96M | -75.69%-123.97M |
| Invest income | -36.44%56.5M | -41.57%40.02M | 16.57%17.11M | 143.50%82.26M | 187.28%88.89M | 170.63%68.49M | 13.40%14.68M | -98.70%33.78M | 75.47%30.94M | 655.19%25.31M |
| -Including: Investment income associates | 24.53%56.16M | 13.80%39.74M | 77.82%16.66M | 23.34%40.37M | 54.21%45.1M | 47.03%34.92M | -14.33%9.37M | 254.90%32.73M | 469.33%29.25M | 467.47%23.75M |
| Asset deal income | -52.45%20.42M | 94.93%21.29M | 94,976.59%4.68M | -2.27%35.68M | 17,643.84%42.95M | 6,051.76%10.92M | --4.92K | -15.45%36.51M | 52.53%242.04K | 12.73%177.57K |
| Other revenue | -5.76%85.81M | -23.38%51.85M | -63.10%15.8M | 56.14%123.47M | 75.39%91.05M | 83.38%67.67M | 255.84%42.82M | -24.74%79.08M | -37.86%51.91M | -48.44%36.9M |
| Adjusted Items effecting operating profit | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -18.68%655.29M | -25.87%484.5M | -34.76%270.27M | 30.84%788.27M | 88.28%805.82M | 85.55%653.61M | 123.59%414.27M | -76.23%602.46M | 8.08%428M | -5.53%352.26M |
| Add:Non operating Income | 1.41%949.1K | -30.27%522.47K | 82.05%323.54K | -39.57%1.11M | -11.64%935.93K | 99.54%749.33K | -43.61%177.72K | -10.28%1.84M | -14.90%1.06M | -46.72%375.54K |
| Less:Non operating expense | -31.94%8.54M | -80.73%2.3M | -88.88%1.2M | 51.72%21.69M | -32.01%12.55M | 30.95%11.94M | 696.98%10.78M | 47.53%14.3M | 279.98%18.46M | 441.18%9.12M |
| Total profit | -18.45%647.7M | -24.86%482.72M | -33.26%269.39M | 30.11%767.69M | 93.42%794.21M | 87.01%642.42M | 119.09%403.67M | -76.65%590.01M | 4.64%410.6M | -7.64%343.52M |
| Less:Income tax cost | 7.63%101.52M | 12.57%75.17M | -49.96%39.43M | -28.43%92.97M | -11.76%94.32M | -16.93%66.77M | 58.87%78.79M | -66.79%129.89M | 21.00%106.89M | 11.23%80.38M |
| Add:Adjusted items effecting net profit | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | -21.96%546.18M | -29.20%407.56M | -29.21%229.96M | 46.64%674.72M | 130.45%699.89M | 118.76%575.65M | 141.27%324.87M | -78.46%460.12M | -0.12%303.71M | -12.19%263.13M |
| Net profit from continuing operation | -21.96%546.18M | -29.20%407.56M | -29.21%229.96M | 46.64%674.72M | 130.45%699.89M | 118.76%575.65M | 141.27%324.87M | -7.70%460.12M | -0.12%303.71M | -12.19%263.13M |
| Less:Minority Profit | -63.83%27.73M | -57.39%25.36M | -65.81%13.9M | -18.48%83.15M | 3.05%76.65M | 17.28%59.51M | 29.66%40.66M | -13.78%102M | -12.07%74.38M | -6.11%50.74M |
| Net profit of parent company owners | -16.81%518.46M | -25.95%382.2M | -23.98%216.06M | 65.19%591.57M | 171.76%623.24M | 143.01%516.13M | 175.17%284.21M | -82.25%358.12M | 4.49%229.33M | -13.52%212.39M |
| Earning per share | ||||||||||
| Basic earning per share | -15.64%0.205 | -25.37%0.15 | -24.32%0.084 | 64.29%0.23 | 173.03%0.243 | 142.17%0.201 | 177.50%0.111 | -82.05%0.14 | 4.71%0.089 | -13.54%0.083 |
| Diluted earning per share | -15.35%0.204 | -25.63%0.148 | -24.32%0.084 | 64.29%0.23 | 170.79%0.241 | 139.76%0.199 | 177.50%0.111 | -82.05%0.14 | 4.71%0.089 | -13.54%0.083 |
| Other composite income | 81.23K | -242.95K | 40.16%-104.31K | -928.50%-174.32K | 15,712.52%455.32K | |||||
| Other composite income of parent company owners | --81.23K | ---- | ---242.95K | 38.35%-104.31K | ---- | ---- | ---- | -921.92%-169.2K | 15,712.53%444.8K | ---- |
| Other composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,206.91%-5.12K | 15,712.04%10.52K | ---- |
| Total composite income | -21.95%546.27M | -29.20%407.56M | -29.29%229.72M | 46.67%674.62M | 130.10%699.89M | 118.76%575.65M | 141.35%324.87M | -78.46%459.94M | 0.03%304.16M | -12.26%263.13M |
| Total composite income of parent company owners | -16.80%518.54M | -25.95%382.2M | -24.06%215.82M | 65.24%591.47M | 171.24%623.24M | 143.01%516.13M | 175.28%284.21M | -82.26%357.95M | 4.69%229.78M | -13.61%212.39M |
| Total composite income of minority owners | -63.83%27.73M | -57.39%25.36M | -65.81%13.9M | -18.47%83.15M | 3.04%76.65M | 17.28%59.51M | 29.66%40.66M | -13.79%101.99M | -12.06%74.39M | -6.12%50.74M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
